These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 15064943)

  • 41. Fabry disease: detection of undiagnosed hemodialysis patients and identification of a "renal variant" phenotype.
    Nakao S; Kodama C; Takenaka T; Tanaka A; Yasumoto Y; Yoshida A; Kanzaki T; Enriquez AL; Eng CM; Tanaka H; Tei C; Desnick RJ
    Kidney Int; 2003 Sep; 64(3):801-7. PubMed ID: 12911529
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Fabry's disease--a comprehensive review on pathogenesis, diagnosis and treatment.
    Mahmud HM
    J Pak Med Assoc; 2014 Feb; 64(2):189-94. PubMed ID: 24640811
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Fabry disease mimicking multiple sclerosis.
    Saip S; Uluduz D; Erkol G
    Clin Neurol Neurosurg; 2007 May; 109(4):361-3. PubMed ID: 17234336
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Fabry disease: cardiac manifestations and therapeutic options.
    Pierre-Louis B; Kumar A; Frishman WH
    Cardiol Rev; 2009; 17(1):31-5. PubMed ID: 19092368
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Neurological features of Fabry disease: clinical, pathophysiological aspects and therapy.
    Bersano A; Lanfranconi S; Valcarenghi C; Bresolin N; Micieli G; Baron P
    Acta Neurol Scand; 2012 Aug; 126(2):77-97. PubMed ID: 22428782
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical spectrum of Anderson Fabry disease in a Romanian family.
    Tudor A; Muşat A; Doscan A; Bari M; Zapucioiu C; Urdea E; Cochior D; Peţa D
    Rom J Intern Med; 2006; 44(2):201-10. PubMed ID: 17236300
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Nature and prevalence of pain in Fabry disease and its response to enzyme replacement therapy--a retrospective analysis from the Fabry Outcome Survey.
    Hoffmann B; Beck M; Sunder-Plassmann G; Borsini W; Ricci R; Mehta A;
    Clin J Pain; 2007; 23(6):535-42. PubMed ID: 17575495
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Fabry disease: overall effects of agalsidase alfa treatment.
    Beck M; Ricci R; Widmer U; Dehout F; de Lorenzo AG; Kampmann C; Linhart A; Sunder-Plassmann G; Houge G; Ramaswami U; Gal A; Mehta A
    Eur J Clin Invest; 2004 Dec; 34(12):838-44. PubMed ID: 15606727
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Kidney transplantation and enzyme alpha-galactosidase A therapy in patient with Fabry disease: a case report.
    Dziemianko I; Jezior D; Boratyńska M; Patrzałek D; Kuźniar J; Szyber P; Klinger M
    Transplant Proc; 2007 Nov; 39(9):2925-7. PubMed ID: 18022018
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Later-onset Fabry disease: an adult variant presenting with the cramp-fasciculation syndrome.
    Nance CS; Klein CJ; Banikazemi M; Dikman SH; Phelps RG; McArthur JC; Rodriguez M; Desnick RJ
    Arch Neurol; 2006 Mar; 63(3):453-7. PubMed ID: 16533976
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Neurological aspects of Fabry disease].
    Clavelou P; Besson G
    Presse Med; 2007 Mar; 36 Spec No 1():1S65-8. PubMed ID: 17546771
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Fabry disease.
    Tarabuso AL
    Skinmed; 2011; 9(3):173-7. PubMed ID: 21675497
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Results of enzyme replacement therapy in Fabry disease nephropathy].
    Dussol B
    Presse Med; 2007 Mar; 36 Spec No 1():1S43-7. PubMed ID: 17546767
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Paediatric Fabry disease.
    Ellaway C
    Transl Pediatr; 2016 Jan; 5(1):37-42. PubMed ID: 26835405
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Fabry disease].
    Kantola I; Penttinen M; Nuutila P; Viikari J
    Duodecim; 2012; 128(7):729-39. PubMed ID: 22612023
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evolution of renal pathology in Fabry disease.
    Sessa A; Meroni M; Battini G; Righetti M; Nebuloni M; Tosoni A; Vago GL;
    Acta Paediatr Suppl; 2003 Dec; 92(443):6-8; discussion 5. PubMed ID: 14989458
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Oxidative Stress and Cardiovascular-Renal Damage in Fabry Disease: Is There Room for a Pathophysiological Involvement?
    Ravarotto V; Simioni F; Carraro G; Bertoldi G; Pagnin E; Calò LA
    J Clin Med; 2018 Nov; 7(11):. PubMed ID: 30400144
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Palm-Plant Pain, Sign of a Severe Systemic Disease? Case Report and Review of Literature.
    Starcea IM; Bodescu Amancei Ionescu L; Lazaruc TI; Lupu VV; Bogos RA; Ioniuc I; Dragan F; Lupu A; Galatanu LS; Miron IC; Mocanu A
    Genes (Basel); 2023 Feb; 14(2):. PubMed ID: 36833443
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Variable phenotypic presentations of renal involvement in Fabry disease: a case series.
    McCloskey S; Brennan P; Sayer JA
    F1000Res; 2018; 7():356. PubMed ID: 29770213
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Treatment of Fabry Disease: Established and Emerging Therapies.
    Umer M; Kalra DK
    Pharmaceuticals (Basel); 2023 Feb; 16(2):. PubMed ID: 37259462
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.